OA11635A - Process for the preparation of paroxetine hydrochloride. - Google Patents
Process for the preparation of paroxetine hydrochloride. Download PDFInfo
- Publication number
- OA11635A OA11635A OA1200000182A OA1200000182A OA11635A OA 11635 A OA11635 A OA 11635A OA 1200000182 A OA1200000182 A OA 1200000182A OA 1200000182 A OA1200000182 A OA 1200000182A OA 11635 A OA11635 A OA 11635A
- Authority
- OA
- OAPI
- Prior art keywords
- paroxetine hydrochloride
- propan
- disorders
- paroxetine
- solvaté
- Prior art date
Links
- AHOUBRCZNHFOSL-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine Chemical compound C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title claims abstract description 75
- 229960005183 paroxetine hydrochloride Drugs 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000006184 cosolvent Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- 238000002425 crystallisation Methods 0.000 claims description 9
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 claims description 6
- 229960002296 paroxetine Drugs 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000011321 prophylaxis Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 2
- 206010036618 Premenstrual syndrome Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010041250 Social phobia Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000000648 anti-parkinson Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- AKPUJVVHYUHGKY-UHFFFAOYSA-N hydron;propan-2-ol;chloride Chemical compound Cl.CC(C)O AKPUJVVHYUHGKY-UHFFFAOYSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000002271 trichotillomania Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726907.0A GB9726907D0 (en) | 1997-12-19 | 1997-12-19 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11635A true OA11635A (en) | 2004-11-22 |
Family
ID=10823933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200000182A OA11635A (en) | 1997-12-19 | 1998-12-18 | Process for the preparation of paroxetine hydrochloride. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1042318A1 (id) |
| JP (1) | JP2001526288A (id) |
| KR (1) | KR20010033317A (id) |
| CN (1) | CN1281448A (id) |
| AP (1) | AP2000001836A0 (id) |
| AU (1) | AU1769899A (id) |
| BG (1) | BG104604A (id) |
| BR (1) | BR9813638A (id) |
| CA (1) | CA2315066A1 (id) |
| EA (1) | EA200000689A1 (id) |
| GB (1) | GB9726907D0 (id) |
| HU (1) | HUP0004503A3 (id) |
| ID (1) | ID24733A (id) |
| IL (1) | IL136590A0 (id) |
| NO (1) | NO20003145L (id) |
| OA (1) | OA11635A (id) |
| PL (1) | PL341358A1 (id) |
| SK (1) | SK9242000A3 (id) |
| TR (1) | TR200001933T2 (id) |
| WO (1) | WO1999032484A1 (id) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9919001D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel process |
| GB9923439D0 (en) * | 1999-10-04 | 1999-12-08 | Smithkline Beecham Plc | Novel process |
| NL1017421C2 (nl) | 2001-02-21 | 2002-01-15 | Synthon Bv | Werkwijze voor het vervaardigen van paroxetine. |
| WO2003072104A1 (en) * | 2002-02-22 | 2003-09-04 | Teva Pharmaceutical Industries Ltd. | Preparation of paroxetine involving novel intermediates |
| KR100672184B1 (ko) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | 파록세틴의 콜린산 또는 콜린산 유도체 염 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
| CA2187128A1 (en) * | 1996-10-04 | 1997-06-26 | K. S. Keshava Murthy | New and useful polymorph of anhydrous paroxetine hydrochloride |
-
1997
- 1997-12-19 GB GBGB9726907.0A patent/GB9726907D0/en not_active Ceased
-
1998
- 1998-12-18 EP EP98962563A patent/EP1042318A1/en not_active Withdrawn
- 1998-12-18 PL PL98341358A patent/PL341358A1/xx unknown
- 1998-12-18 SK SK924-2000A patent/SK9242000A3/sk unknown
- 1998-12-18 AU AU17698/99A patent/AU1769899A/en not_active Abandoned
- 1998-12-18 OA OA1200000182A patent/OA11635A/en unknown
- 1998-12-18 AP APAP/P/2000/001836A patent/AP2000001836A0/en unknown
- 1998-12-18 ID IDW20001158A patent/ID24733A/id unknown
- 1998-12-18 KR KR1020007006764A patent/KR20010033317A/ko not_active Withdrawn
- 1998-12-18 JP JP2000525421A patent/JP2001526288A/ja active Pending
- 1998-12-18 CA CA002315066A patent/CA2315066A1/en not_active Abandoned
- 1998-12-18 CN CN98811920A patent/CN1281448A/zh active Pending
- 1998-12-18 TR TR2000/01933T patent/TR200001933T2/xx unknown
- 1998-12-18 BR BR9813638-0A patent/BR9813638A/pt not_active Application Discontinuation
- 1998-12-18 HU HU0004503A patent/HUP0004503A3/hu unknown
- 1998-12-18 WO PCT/GB1998/003836 patent/WO1999032484A1/en not_active Ceased
- 1998-12-18 IL IL13659098A patent/IL136590A0/xx unknown
- 1998-12-18 EA EA200000689A patent/EA200000689A1/ru unknown
-
2000
- 2000-06-16 NO NO20003145A patent/NO20003145L/no not_active Application Discontinuation
- 2000-07-13 BG BG104604A patent/BG104604A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1042318A1 (en) | 2000-10-11 |
| WO1999032484A1 (en) | 1999-07-01 |
| GB9726907D0 (en) | 1998-02-18 |
| HUP0004503A3 (en) | 2002-04-29 |
| CA2315066A1 (en) | 1999-07-01 |
| CN1281448A (zh) | 2001-01-24 |
| AU1769899A (en) | 1999-07-12 |
| KR20010033317A (ko) | 2001-04-25 |
| ID24733A (id) | 2000-08-03 |
| EA200000689A1 (ru) | 2000-12-25 |
| NO20003145D0 (no) | 2000-06-16 |
| TR200001933T2 (tr) | 2000-12-21 |
| JP2001526288A (ja) | 2001-12-18 |
| SK9242000A3 (en) | 2001-01-18 |
| BG104604A (en) | 2001-03-30 |
| PL341358A1 (en) | 2001-04-09 |
| IL136590A0 (en) | 2001-06-14 |
| HUP0004503A2 (hu) | 2002-03-28 |
| BR9813638A (pt) | 2000-10-17 |
| AP2000001836A0 (en) | 2000-06-30 |
| NO20003145L (no) | 2000-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA11635A (en) | Process for the preparation of paroxetine hydrochloride. | |
| WO2000035910A1 (en) | Derivative of paroxetine | |
| JP2002531451A (ja) | パロキセチン塩酸塩の製法 | |
| MXPA00006040A (en) | Process for the preparation of paroxetine hydrochloride | |
| WO2000078753A1 (en) | Process for the preparation of paroxetine and structurally related compounds | |
| CA2323896A1 (en) | Crystalline form of paroxetine | |
| WO2001046148A1 (en) | Novel processes | |
| AU5428999A (en) | Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride | |
| CZ20002256A3 (cs) | Způsob přípravy paroxetinhydrochloridu | |
| EP1135383B1 (en) | Mixed paroxetine propan-2-ol solvates | |
| WO2001012623A1 (en) | Process for the preparation of paroxetine hydrochloride | |
| EP1140910A1 (en) | Process for the preparation of an acetate salt of paroxetine or paroxetine analogues | |
| WO2000039090A1 (en) | Process for the preparation of paroxetine acetate and analogues thereof | |
| US20010008940A1 (en) | Novel process | |
| EP1155016A1 (en) | Process for the production of paroxetine hydrochloride acetone solvate | |
| EP1140911A1 (en) | Process for the preparation of an acetate salt of paroxetine or paroxetine analogues | |
| WO2001014335A1 (en) | Process for preparation of paroxetin intermediate | |
| EP1140912A1 (en) | Process for the preparation of an acetate salt of paroxetine or paroxetine analogues | |
| MXPA00009137A (es) | Forma cristalina de paroxetina | |
| WO2000032592A1 (en) | Process for the preparation of paroxetine hydrochloride |